YOLFTbeta
ReWalk Robotics Ltd

ReWalk Robotics Ltd

LFWD · NASDAQ · Healthcare / Medical Devices

4.06USD-1.66 (-29.02%)

Price History

Full chart

Market Stats

Previous Close5.72
Open5.42
Day Range3.81 – 5.42
52-Week Range4.14 – 10.20
Volume30.37K
Market Cap19.80M
P/E (TTM)0.00
Forward P/E0.00
EPS-14.66
Dividend Yield0.00%
Beta0.40
50-Day Avg7.28
200-Day Avg7.18

About

Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as ReWalk Robotics Ltd. and changed its name to Lifeward Ltd. in September 2024. Lifeward Ltd. was incorporated in 2001 and is based in Yokneam Illit, Israel.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Joshua Hexter
  • Employees81
  • Headquarters3 Hatnufa St., Yokneam Illit, Israel, 2069203, USA
  • Websitehttps://golifeward.com

Leadership

  • Mr. Almog AdarChief Financial Officer · b. 1984
  • Mr. William Mark GrantSenior Advisor · b. 1970
  • Mr. Joshua HexterInterim Chief Executive Officer · b. 1970
  • Ms. Miri ParienteVice President of Operations, Regulatory & Quality · b. 1977
  • Dr. Keith Dale Rose M.D.Chief Medical Officer
  • Mr. Craig Peters DPTVice President of Sales - North America

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.87M7.75M6.54M4.87M4.39M5.97M5.51M13.85M25.66M22.03M
Growth (%)-+32.10%-15.58%-25.55%-9.85%+35.81%-7.63%+151.39%+85.24%-14.14%
Cost of Revenue5.13M4.65M3.72M2.15M2.20M3.06M3.61M9.40M17.45M13.61M
Gross Profit736.00K3.10M2.83M2.73M2.19M2.90M1.91M4.45M8.22M8.43M
Gross Margin12.54%40.00%43.16%55.94%49.83%48.66%34.57%32.14%32.01%38.25%
Operating Expense31.18M25.09M22.04M16.77M14.19M15.56M21.01M28.07M27.77M25.32M
Operating Income-30.44M-21.99M-19.21M-14.05M-12.00M-12.65M-19.10M-23.61M-19.55M-16.89M
Operating Margin-518.67%-283.66%-293.57%-288.28%-273.25%-212.12%-346.62%-170.43%-76.19%-76.66%
EBITDA-29.79M-21.48M-18.79M-13.72M-11.73M-12.39M-18.90M-20.28M-24.93M-19.34M
EBITDA Margin-507.65%-276.99%-287.14%-281.63%-267.08%-207.66%-342.95%-146.37%-97.14%-87.78%
Net Income-32.50M-24.72M-21.68M-15.55M-12.98M-12.74M-19.57M-22.13M-28.94M-19.91M
Net Income Margin-553.81%-318.81%-331.17%-319.13%-295.38%-213.48%-355.09%-159.76%-112.78%-90.38%
R&D9.03M6.04M7.35M5.35M3.46M2.94M4.03M4.15M4.63M3.25M
R&D as % of Total Revenue153.83%77.93%112.28%109.75%78.74%49.26%73.14%29.94%18.02%14.75%
Interest Expense2.01M2.48M2.42M1.53M930.00K25.00K22.00K20.00K128.00K295.00K
Interest Expense % of Total Revenue34.25%32.00%37.04%31.40%21.17%0.42%0.40%0.14%0.50%1.34%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-09-302020-12-312021-09-302021-12-312022-09-302022-12-312023-09-302023-12-312024-12-312025-12-31
Total Assets31.76M22.86M14.96M24.37M28.07M28.07M94.75M94.75M74.24M74.24M63.19M63.19M30.49M22.90M
Total Liabilities23.50M19.16M13.02M13.59M6.29M6.29M5.37M5.37M6.07M6.07M16.68M16.68M11.64M14.49M
Total Equity8.26M3.71M1.95M10.78M21.77M21.77M89.38M89.38M68.17M68.17M46.51M46.51M18.85M8.41M
Cash23.68M14.57M9.55M16.25M20.35M20.35M88.34M88.34M67.90M67.90M28.08M28.08M6.94M2.17M
Total Debt18.01M15.35M8.69M8.92M1.58M1.58M1.06M1.06M897.00K897.00K1.90M1.90M880.00K4.39M
Net Debt-5.67M785.00K-859.00K-7.34M-18.77M-18.77M-87.28M-87.28M-67.00M-67.00M-26.18M-26.18M-6.06M2.22M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-27.54M-22.50M-14.77M-14.81M-12.59M-11.47M-17.89M-20.67M-21.72M-16.83M
Investing Cash Flow-437.00K-21.00K-13.00K-22.00K-73.00K-47.00K-25.00K-18.15M--16.00K
Financing Cash Flow33.78M13.41M9.71M21.48M16.72M79.51M-2.50M-992.00K012.20M
Capital Expenditure452.00K21.00K13.00K22.00K73.00K47.00K25.00K81.00K016.00K
Free Cash Flow-27.99M-22.52M-14.79M-14.84M-12.66M-11.52M-17.92M-20.75M-21.72M-16.83M
FCF to OCF101.64%100.09%100.09%100.15%100.58%100.41%100.14%100.39%100.00%100.00%

Earnings

Report DateNov 13, 2014Feb 12, 2015May 7, 2015Aug 6, 2015Nov 5, 2015Feb 25, 2016May 5, 2016Aug 4, 2016Nov 3, 2016Feb 17, 2017May 4, 2017Aug 3, 2017Nov 2, 2017Mar 8, 2018May 10, 2018Aug 14, 2018Nov 8, 2018Feb 8, 2019May 7, 2019Aug 8, 2019Nov 13, 2019Feb 20, 2020May 28, 2020Aug 12, 2020Nov 10, 2020Feb 18, 2021May 11, 2021Aug 9, 2021Nov 10, 2021Feb 24, 2022May 13, 2022Aug 9, 2022Nov 7, 2022Feb 23, 2023May 11, 2023Aug 11, 2023Nov 14, 2023Feb 27, 2024May 15, 2024Aug 14, 2024Nov 12, 2024Feb 25, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Mar 18, 2026May 15, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate-553.00-651.00-787.50-840.00-1029.00-13.17-1253.00-1078.00-1204.00-934.50-10.08-805.00-735.00-546.00-0.22-336.00-294.00-294.00-84.00-41.16-37.80-30.24-0.26-22.68-13.44-11.76-5.88-5.04-5.04-3.36-4.20-3.36-5.04-5.88-6.72-5.88-8.40-9.24-8.40-6.60-3.78-0.33-0.33-2.88-1.92-1.08-0.34-1.49-0.53
EPS Actual-2814.00-863.52-1008.00-1008.00-1113.00-0.62-1002.98-1347.78-1095.36-997.29-68.25-602.39-462.21-422.73-36.75-378.00-273.00-210.00-105.00-73.92-38.64-41.16-2.59-18.48-15.12-11.76-6.55-5.88-5.04-5.04-5.57-5.88-7.56-7.56-5.67-5.29-6.72-4.20-7.44-6.00-4.20-0.38-0.46-3.72-2.28-2.85-6.70-1.46-
Surprise-408.86%-32.65%-28.00%-20.00%-8.16%95.29%19.95%-25.03%9.02%-6.72%-577.08%25.17%37.11%22.58%-16604.55%-12.50%7.14%28.57%-25.00%-79.59%-2.22%-36.11%-896.15%18.52%-12.50%0.00%-11.39%-16.67%0.00%-50.00%-32.62%-75.00%-50.00%-28.57%15.63%10.03%20.00%54.55%11.43%9.09%-11.11%-15.15%-39.39%-29.17%-18.75%-163.89%-1870.59%2.01%-
TimingPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap19.80M
Enterprise Value17.19M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.91
Price / Book1.61
EPS-14.66
Book Value4.32
Revenue (TTM)21.82M
Gross Profit (TTM)7.85M
EBITDA-22.98M
Profit Margin-141.28%
Operating Margin-62.69%
Return on Equity-225.65%
Return on Assets-47.26%
Shares Outstanding2.83M
Shares Float1.57M
Beta0.40
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 3 analystsTarget 20.00
  • Strong Buy
    1
  • Buy
    2

Ownership Breakdown

Institutions
1.45%
Insiders
48.11%
Retail / Other
50.44%

Top Institutional Holders

  • Citadel Advisors Llc
    18.06K0.64%
  • Renaissance Technologies Corp
    11.43K0.40%
  • UBS Group AG
    2.13K0.07%
  • Morgan Stanley - Brokerage Accounts
    2080.01%
  • SBI Securities Co Ltd
    1960.01%
  • Advisor Group Holdings, Inc.
    1070.00%
  • NATIONAL BANK OF CANADA /FI/
    110.00%
  • Caitong International Asset Management Co., Limited.
    40.00%
  • Group One Trading, LLC
    20.00%
  • HRT FINANCIAL LLC
    00.00%
  • Susquehanna International Group, LLP
    00.00%
  • Jane Street Group LLC
    00.00%
  • Wells Fargo & Co
    00.00%
  • SIMPLEX TRADING, LLC
    00.00%
  • Robertson Stephens Wealth Management, LLC
    00.00%
  • GSA Capital Partners LLP
    00.00%
  • LPL Financial Corp
    00.00%
  • XTX Topco Ltd
    00.00%

Top Fund Holders

  • Dimensional US Core Equity 1 ETF
    8040.03%
  • Dimensional US Core Equity 2 ETF
    970.00%

Stock Splits

  • Feb 24, 20261:12
  • Mar 15, 20241:7
  • Apr 1, 20191:25